​

Monte Rosa Therapeutics (GLUE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Monte Rosa Therapeutics Revenue Highlights

Latest Revenue (Y)

$75.62M

Latest Revenue (Q)

$60.65M

Monte Rosa Therapeutics Revenue by Period

Monte Rosa Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$75.62M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Monte Rosa Therapeutics generated $75.62M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Monte Rosa Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31$60.65M558.06%
2024-09-30$9.22M96.29%
2024-06-30$4.70M341.26%
2024-03-31$1.06M-87.84%
2023-12-31$8.75M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Monte Rosa Therapeutics generated $60.65M in revenue during Q4 2024, up 558.06% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Monte Rosa Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLUEMonte Rosa Therapeutics$75.62M$60.65M
CCCCC4 Therapeutics$20.76M$5.18M
IPSCCentury Therapeutics$6.59M$109.16M
CGEMCullinan Oncology--
NUVLNuvalent--
EWTXEdgewise Therapeutics--
MLYSMineralys Therapeutics--
ERASErasca--

GLUE Revenue FAQ

What is Monte Rosa Therapeutics’s yearly revenue?

Monte Rosa Therapeutics's yearly revenue for 2024 was $75.62M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. GLUE's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Monte Rosa Therapeutics’s quarterly revenue?

Monte Rosa Therapeutics's quarterly revenue for Q4 2024 was $60.65M, a 558.06% increase from the previous quarter (Q3 2024), and a 592.95% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $9.22M, a 96.29% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). GLUE's quarterly revenue for Q2 2024 was $4.7M, a 341.26% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Monte Rosa Therapeutics’s revenue growth rate?

Monte Rosa Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.